Clostridium difficile and Clostridium perfringens research
Moving in bioRxiv, Gastroenterology, mSystems, The lancet. Gastroenterology & hepatology, Gut, Journal of bacteriology, Nature Reviews Microbiology and Nature reviews. Gastroenterology & hepatology.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 30
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Clostridium difficile and Clostridium perfringens research
Newest first · last 60 days
Gut microbiome signatures are weakly associated with colorectal neoplasia and do not serve as robust early biomarkers in a large cross-sectional study.
- Open access
Lincosamides, penicillins, sulfonamides, and cephalosporins are linked to significantly increased CDI risk, with lincosamides showing the highest adjusted OR of 31.4 in the Swedish population.
- Open access
- 3 cites
Fecal microbiota transplantation may improve irritable bowel syndrome symptoms at 12 weeks, but evidence remains very uncertain, based on 13 RCTs with 693 patients.
- Open access
- 1 cites
Consuming sugar-rich foods during antibiotic treatment worsens gut microbiome disruption, increasing Enterococcus expansion and reducing microbial diversity.
- Open access
- 1 cites
Clostridioides difficile produces over 28 unique N-acyl amino acids, including high levels of phenylacetic acid, distinguishing it from other gut bacteria.
- Open access
A single Faecalibacterium prausnitzii EXL01 strain significantly reduces recurrent Clostridioides difficile infection in humans, with 83.3% remaining recurrence-free at 8 weeks.
DCA exposure promotes a metabolic interaction between Escherichia coli and Clostridioides difficile that enhances CDI severity through proline cross-feeding.
- Open access
Multiple toxin-antitoxin systems in Helicobacter pylori are linked to key adaptive processes, including biofilm formation and stress responses, with at least 10 validated systems.
- Open access
C. difficile assembles a unique divisome complex in three phases, with PBP1 replacing FtsW-FtsI in septal peptidoglycan synthesis, highlighting a distinct bacterial division mechanism.
- Open access
Bioengineering Escherichia coli Nissle 1917 with the ttr operon enables effective treatment of colitis by promoting colonization during inflammation, outperforming traditional therapies.
- Open access
Add Clostridium difficile and Clostridium perfringens research as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6131
- medRxiv1703
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3